Clinical Trial Update: Efficacy and Safety of SR1375 in Adult Patients With CAP [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SR1375 in adults with community-acquired pneumonia, highlighting the ongoing assessment of efficacy and safety and current rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• SR1375

Snippet

Sponsor: Shanghai SIMR Biotechnology Co., Ltd. | Conditions: Community-acquired Pneumonia | Phase 2 | Status: RECRUITING